Brain

Alternative pathways let right and left communicate in early split brains

During the last century, many patients have undergone a variety of brain surgeries in an attempt to alleviate all sorts of psychiatric maladies, from hysteria and depression (mainly in women) to schizophrenia and epilepsy. Early on, doctors believed that psychiatric patients suffered from aberrant wiring among different brain areas and that cutting the connections between these areas would help patients regain normal brain circuits as well as their mental health.

Bullying may have long-term health consequences

DURHAM, N.C. -- Bullied children may experience chronic, systemic inflammation that persists into adulthood, while bullies may actually reap health benefits of increasing their social status through bullying, according to researchers at Duke Medicine.

The study, conducted in collaboration with the University of Warwick, the University of North Carolina at Chapel Hill and Emory University, is published online in the Proceedings of the National Academy of Sciences the week of May 12, 2014.

Henry Ford researchers identify genetic factors that may aid survival from brain cancer

DETROIT – A Henry Ford Hospital research team has identified specific genes that may lead to improved survival of glioblastoma, the most common and deadly form of cancerous brain tumor.

The molecular data is expected to aid further research into genes that either help or impede the survival of patients diagnosed with the tumor, which can invade and rapidly grow in any part of the human brain.

Role of pro-urokinase in neuronal apoptosis and revascularization after ACI

Among the drugs used for acute ischemic stroke, recombinant tissue plasminogen activator is widely accepted internationally. In China, urokinase has been widely used for thrombolysis after acute ischemic stroke. Pro-urokinase is the precursor of urokinase. Compared with urokinase, pro-urokinase has greater ability to dissolve thrombus and is safer to use. However, most countries do not recognize urokinase for thrombolytic treatment after acute ischemic stroke, which has not been approved for clinical use. Dr.

Unusual neural connection between injured cingulum and brainstem in a SAH patients

The cingulum is an important pathway for cholinergic innervation for the cerebral cortex. Many studies have reported connections between the cholinergic nuclei, especially between the cholinergic nuclei in the basal forebrain and those in the brainstem via the fornix and thalamus. However, little is known about the connection between cholinergic nuclei in the basal forebrain and cholinergic nuclei in the brainstem via the cingulum. Even no study on this phenomenon after cerebral hemorrhage has been reported. Dr.

Molecular regulation of hypoxic-ischemic brain damage

Oligodendrocyte lineage gene 1 (Olig1) plays a key role in hypoxic-ischemic brain damage and myelin repair. miRNA-9 is involved in the occurrence of many related neurological disorders. Bioinformatics analysis demonstrated that miRNA-9 complementarily, but incompletely, bound oligodendrocyte lineage gene 1, but whether miRNA-9 regulates oligodendrocyte lineage gene 1 remains poorly understood. Dr.

Recombinant adenovirus-mediated 3β-hydroxysteroid-Δ24 reductase inhibits neural apoptosis

3β-Hydroxysteroid-Δ24 reductase (DHCR24) is a multifunctional enzyme that localizes to the endoplasmic reticulum and has neuroprotective and cholesterol-synthesizing activities. DHCR24 overexpression confers neuroprotection against apoptosis caused by amyloid β deposition. Dr. Xiuli Lu and colleagues from Liaoning University in China constructed two recombinant adenoviruses (Ad-rSYN1-DHCR24-myc and Ad-hSYN1-DHCR24-myc) that drive DHCR24 expression specifically in neuronal cells.

ADHD treatment associated with lower smoking rates

DURHAM, N.C. -- Treating attention deficit hyperactivity disorder (ADHD) with stimulant medication may reduce smoking risk, especially when medication is taken consistently, according to an analysis led by researchers at Duke Medicine.

The findings appear online May 12, 2014, in the journal Pediatrics.

Longevity gene may boost brain power

Scientists showed that people who have a variant of a longevity gene, called KLOTHO, have improved brain skills such as thinking, learning and memory regardless of their age, sex, or whether they have a genetic risk factor for Alzheimer's disease. Increasing KLOTHO gene levels in mice made them smarter, possibly by increasing the strength of connections between nerve cells in the brain. The study was partly funded by the National Institutes of Health.

Autism-related protein shown to play vital role in addiction

BELMONT - In a paper published in the latest issue of the neuroscience journal Neuron, McLean Hospital investigators report that a gene essential for normal brain development, and previously linked to Autism Spectrum Disorders, also plays a critical role in addiction-related behaviors.

Love makes you strong

It is springtime and they are everywhere: Newly enamored couples walking through the city hand in hand, floating on cloud nine. Yet a few weeks later the initial rush of romance will have dissolved and the world will not appear as rosy anymore. Nevertheless, love and romance have long lasting effects.

How to increase the survival rate of motor neurons after spinal root avulsion

A previous study showed that, 1 week after avulsion of the spinal nerve root, small motor neurons (< 500 μm2) negative for 27 kDa heat shock protein (HSP27) immunoreactivity died and only large (> 500 μm2) HSP27-positive motor neurons survived in the spinal cord ventral horn. This was followed by the enhancement of HSP27 expression in motor neurons observed after mild crush of the spinal nerve root. Dr.

Overexpression of Notch1 in temporal lobe epilepsy

Notch1 signaling can induce astrogliosis in glioma. However, it remains unknown whether Notch1 signaling is involved in the pathogenesis of epilepsy. A recent study by Xijin Liu and co-workers from Huazhong University of Science and Technology in China observed overexpression of Notch1 in the brain tissue of temporal lobe epilepsy rats. After Notch1 regulation, it was relatively effective in reducing seizure frequency and reducing brain discharges, thereby resulting in the ease of seizures to a certain extent.

Implantable device to beat high blood pressure

An implantable device that reduces blood pressure by sending electrical signals to the brain has been created by a group of researchers in Germany.

The device has successfully reduced the blood pressure in rats by 40 per cent without any major side effects, and could offer hope for a significant proportion of patients worldwide who do not respond to existing medical treatment for the condition.

The first results have been published today, 9 May, in IOP Publishing's Journal of Neural Engineering.

Neurovance's EB-1020 SR for adult ADHD shows stimulant-like efficacy in Phase 2a trial

Neurovance, Inc. today announced complete results from its phase 2a pilot study of EB-1020 SR, a non-stimulant, in adult male patients with all subtypes of ADHD (attention deficit hyperactivity disorder). EB-1020 SR is a norepinephrine- and dopamine-preferring triple reuptake inhibitor. The data showed a statistically significant improvement in ADHD symptoms on the ADHD-Rating Scale-IV (ADHD-RS-IV), the primary outcome measure, in a range similar to that reported in previously published trials with stimulants. EB-1020 SR appears to be well tolerated at the doses studied.